FMCG firm on Monday reported a 12.3 per cent decline in its net profit to ₹67.5 crore in the March quarter of FY’26, on a year-on-year basis.
It had posted a consolidated net profit of ₹77 crore in the January-March quarter a year ago, according to a regulatory filing by Jyothy Labs, which owns brands such as Ujala, Pril, Margo and Exo.
Jyothy Labs’ revenue from operations was up 7.72 per cent to ₹717.41 crore in the March quarter of FY26.
The revenue growth was driven by “10.8 per cent volume growth year-on-year,” said Jyothy Labs in an earning statement.
However, the operating EBITDA margin stood at 13.5 per cent, due to lower sales realisation and inflation in input prices, it added.
Total expenses of Jyothy Labs was at ₹637.7 crore, up 11.8 per cent in the March quarter.
Its total revenue was up 7.6 per cent to ₹733.20 crore in the March quarter.
In the entire FY26, Jyothy Labs reported a profit of ₹333.19 crore, down 10.23 per cent. Total consolidated income rose 3.87 per cent to ₹3,011.85 crore during the financial year ended March 2026.
FY26 was marked by uneven demand and elevated input costs, particularly in the latter part of the year due to developments in West Asia, the company said.
“Despite these headwinds, the company delivered consistent volume growth across the year, supported by calibrated grammage actions and a gradual recovery in consumption, especially in the second half,” it added.
Additionally, GST rate reduction helped stimulate demand, particularly in the Personal Care segment from the third quarter onwards.
“Rural demand remained relatively stable through most of the year, while urban demand showed improvement following GST rate changes,” it said, adding organised channels, including Modem Trade, E-commerce, and Quick Commerce, continued to grow faster and increase their share of sales.
Over the outlook, Chairperson and Managing Director M R Jyothy, said the company remains ‘cautious’ as input costs rose sharply towards the end of the year, driven by crude-linked inflation and developments in West Asia.
Calibrated pricing actions have been taken, though the full impact is yet to flow through. As a result, margins may remain under pressure in the near term, she said.
“Demand is gradually stabilising, though its trajectory in the coming months remains contingent on broader macro environmental factors,” said Jyothy.
Shares of Jyothy Labs Ltd on Monday settled at ₹268.85 per share on BSE, up 1.22 per cent.